triazoles has been researched along with Ewing Sarcoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerman, OC; Fleuren, ED; Flucke, UE; Hillebrandt-Roeffen, MH; Te Loo, DM; van der Graaf, WT; Versleijen-Jonkers, YM | 1 |
| Buch, T; Burdach, S; Calzada-Wack, J; Giorgi, C; Hensel, T; Neff, F; Niggli, FK; Richter, GH; Schäfer, BW; Schmidt, O | 1 |
| Baloglu, E; Cao, Q; Chu, P; Doan, N; Forscher, C; Gery, S; Guo, X; Koeffler, HP; Lee, VK; Lim, HJ; Lin, DC; Marijon, H; Mayakonda, A; Pang, B; Rajalingam, R; Said, JW; Shacham, S; Sun, H; Thomas, T; Xu, L; Yang, H; Zhao, Z | 1 |
| Amiaud, J; Baud'huin, M; Bradner, JE; Heymann, D; Jacques, C; Lamoureux, F; Ory, B; Quillard, T; Rédini, F; Rodriguez Calleja, L; Tirode, F | 1 |
| Borinstein, SC; Chiang, C; Fleming, JT; Guo, Y; Loganathan, SN; Ma, Y; Tang, N; Wang, J | 1 |
| Alturkmani, H; Baltezor, M; Butte, AJ; Chen, B; Flynn, CA; Godwin, AK; Hyter, S; Ma, Y; Neville, KA; Pessetto, ZY; Rosenthal, HG; Weir, SJ | 1 |
| Cornish, NE; Hoffman, MA; Simonsen, KA | 1 |
| Hara, A; Kawai, G; Kimura, M; Matsuhashi, A; Nagano, A; Ohno, T; Okano, Y; Saio, M; Saitou, M; Shimizu, K; Takigami, I; Yamada, K | 1 |
8 other study(ies) available for triazoles and Ewing Sarcoma
| Article | Year |
|---|---|
The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma.
Topics: Adolescent; Adult; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Survival; Child; Child, Preschool; Female; Humans; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Sarcoma, Ewing; Triazoles; Young Adult | 2014 |
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azepines; Bone Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred BALB C; Mice, Knockout; Molecular Targeted Therapy; Nuclear Proteins; Oncogene Proteins, Fusion; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Protein c-fli-1; RNA Interference; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Signal Transduction; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Synergism; Exportin 1 Protein; Female; Gene Knockdown Techniques; Humans; Hydrazines; Imidazoles; Immunoblotting; Immunohistochemistry; Insulin-Like Growth Factor I; Karyopherins; Mice; Mice, Nude; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Pyrazines; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; RNA-Binding Protein EWS; Sarcoma, Ewing; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2016 |
Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
Topics: Adolescent; Adult; Animals; Apoptosis; Azepines; Biomarkers, Tumor; Bone Neoplasms; Cell Cycle; Cell Movement; Cell Proliferation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Oncogene Proteins, Fusion; Proteins; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; Sarcoma, Ewing; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Young Adult | 2016 |
BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Topics: Animals; Antineoplastic Agents; Autocrine Communication; Azepines; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor I; Mice; Mice, Nude; NIH 3T3 Cells; Oncogene Proteins, Fusion; Proteins; Proto-Oncogene Protein c-fli-1; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Somatomedin; RNA-Binding Protein EWS; Sarcoma, Ewing; Signal Transduction; Transcription, Genetic; Triazoles; Xenograft Model Antitumor Assays | 2016 |
In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Auranofin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computer Simulation; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; Sarcoma, Ewing; Transcription Factors; Triazoles | 2017 |
A painful thigh lesion in an immunocompromised 11-year-old boy.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Humans; Hyphae; Immunocompromised Host; Lung Neoplasms; Male; Pyrimidines; Pythiosis; Pythium; Sarcoma, Ewing; Thigh; Triazoles; Voriconazole | 2011 |
Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Bone Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cyclin-Dependent Kinases; Cytokinesis; Dose-Response Relationship, Drug; HeLa Cells; Humans; Mice; Mice, Nude; Mitosis; Neoplasms; Nocodazole; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Sarcoma, Ewing; Spindle Apparatus; Time Factors; Triazoles; Tubulin Modulators; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |